Acquiring Company
Aker Capital
Acquired Company
Aker BioMarine
NorwayVenture CapitalAngel InvestmentBiotechnologyHealth CareNutritionDescription
Aker Capital has received acceptances for 10.7 million shares from Aker BioMarine's takeover offer. This cash offer of NOK 105 per share aims to gain control of the krill producer. The deal is pending approval by Aker BioMarine’s shareholders on August 17. If approved, shares will be transferred to Aker Capital shortly after.
Other recent acquisitions in Venture Capital and Angel Investment
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Flerie merges with Biosergen in strategic acquisition (June 26, 2026)
- Veracyte, Inc. acquires Convergent Genomics Inc. (September 14, 2026)
- Impact BioMedical to merge with Zoar Ltd. (September 11, 2026)
- Yarrow Bioscience, Inc. Completes Merger with Yarrow Bioscience Operating Company Corp. (September 10, 2026)
- Summit acquires Dallas Research Institute to expand network (September 10, 2026)
- HLB Innovation acquires HLB Cell for therapy hub (September 9, 2026)
Who to call at Aker Capital, and when
When Aker Capital changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Aker Capital raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Aker Capital, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Aker Capital. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Aker Capital makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Aker BioMarine?
Aker BioMarine was acquired by Aker Capital, based in Norway. The deal was reported on July 31, 2026. Aker Capital is a wholly owned subsidiary of Aker ASA. It focuses on industrial investments and strategic growth in various sectors. Aker Capital is privately held and operates in Venture Capital.
When did Aker Capital acquire Aker BioMarine?
Aker Capital's acquisition of Aker BioMarine was reported on July 31, 2026. Aker Capital has received acceptances for 10.7 million shares from Aker BioMarine's takeover offer. This cash offer of NOK 105 per share aims to gain control of the krill producer. The deal is pending approval by Aker BioMarine’s shareholders on August 17. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Aker BioMarine do?
Aker BioMarine is a leading biotech company and a supplier of advanced ingredients derived from the Antarctic krill. The company is committed to sustainability and provides innovative solutions for the nutrition and wellness markets. It is privately held, operating in Biotechnology.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.